NSE - Delayed Quote INR

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

Compare
456.20 -31.10 (-6.38%)
At close: 3:30 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
2,099,880.00
2,087,020.00
2,367,140.00
2,175,840.00
1,879,456.00
--
Cost of Revenue
801,840.00
799,770.00
923,460.00
892,820.00
809,340.00
--
Gross Profit
1,298,040.00
1,287,250.00
1,443,680.00
1,283,020.00
1,070,116.00
--
Operating Expense
1,074,780.00
1,073,210.00
1,114,220.00
1,037,570.00
882,252.00
--
Operating Income
223,260.00
214,040.00
329,460.00
245,450.00
187,864.00
--
Net Non Operating Interest Income Expense
-8,790.00
-8,140.00
-4,130.00
12,610.00
24,789.00
--
Pretax Income
268,880.00
298,690.00
348,080.00
266,420.00
218,723.00
--
Tax Provision
65,750.00
74,060.00
80,870.00
77,870.00
48,140.00
--
Net Income Common Stockholders
203,130.00
224,630.00
267,210.00
188,550.00
170,583.00
--
Diluted NI Available to Com Stockholders
203,130.00
224,630.00
267,210.00
188,550.00
170,583.00
--
Basic EPS
7.58
8.49
10.20
7.20
6.51
--
Diluted EPS
7.54
8.46
10.20
7.20
6.51
--
Basic Average Shares
26,764.93
26,458.19
26,197.06
26,198.00
26,198.00
--
Diluted Average Shares
26,894.33
26,552.01
26,197.06
26,198.00
26,198.00
--
Rent Expense Supplemental
--
--
18,310.00
24,770.00
22,687.00
20,653.00
Total Expenses
1,876,620.00
1,872,980.00
2,037,680.00
1,930,390.00
1,691,592.00
--
Net Income from Continuing & Discontinued Operation
203,130.00
224,630.00
267,210.00
188,550.00
170,583.00
--
Normalized Income
227,947.09
224,630.00
293,763.65
191,897.50
168,629.34
--
Interest Income
--
--
34,280.00
15,460.00
29,924.00
21,680.00
Interest Expense
8,790.00
8,140.00
4,130.00
2,610.00
4,275.00
--
Net Interest Income
-8,790.00
-8,140.00
-4,130.00
12,610.00
24,789.00
--
EBIT
277,670.00
306,830.00
352,210.00
269,030.00
222,998.00
--
EBITDA
301,090.00
323,460.00
364,260.00
284,290.00
233,858.00
--
Reconciled Cost of Revenue
801,840.00
799,770.00
923,460.00
892,820.00
809,340.00
--
Reconciled Depreciation
23,420.00
16,630.00
12,050.00
15,260.00
10,860.00
--
Net Income from Continuing Operation Net Minority Interest
203,130.00
224,630.00
267,210.00
188,550.00
170,583.00
--
Total Unusual Items Excluding Goodwill
-32,850.00
--
-34,590.00
-4,730.00
2,505.00
--
Total Unusual Items
-32,850.00
--
-34,590.00
-4,730.00
2,505.00
--
Normalized EBITDA
333,940.00
323,460.00
398,850.00
289,020.00
231,353.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-8,032.91
--
-8,036.35
-1,382.50
551.34
--
3/31/2020 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers